emodin has been researched along with Parkinson Disease in 3 studies
Emodin: Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as a laxative, but is now used mainly as a tool in toxicity studies.
emodin : A trihydroxyanthraquinone that is 9,10-anthraquinone which is substituted by hydroxy groups at positions 1, 3, and 8 and by a methyl group at position 6. It is present in the roots and barks of numerous plants (particularly rhubarb and buckthorn), moulds, and lichens. It is an active ingredient of various Chinese herbs.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Meena, VK | 1 |
Kumar, V | 1 |
Karalia, S | 1 |
Dangi, RS | 1 |
Sundd, M | 1 |
Garcia, PJB | 1 |
Huang, SK | 1 |
De Castro-Cruz, KA | 1 |
Leron, RB | 1 |
Tsai, PW | 1 |
Pretsch, D | 1 |
Rollinger, JM | 1 |
Schmid, A | 1 |
Genov, M | 1 |
Wöhrer, T | 1 |
Krenn, L | 1 |
Moloney, M | 1 |
Kasture, A | 1 |
Hummel, T | 1 |
Pretsch, A | 1 |
3 other studies available for emodin and Parkinson Disease
Article | Year |
---|---|
Structural and mechanistic insights into modulation of α-Synuclein fibril formation by aloin and emodin.
Topics: alpha-Synuclein; Amyloid; Emodin; Humans; Parkinson Disease | 2022 |
In Silico Neuroprotective Effects of Specific
Topics: Emodin; Humans; Molecular Docking Simulation; Monoamine Oxidase; Neuroprotective Agents; Parkinson D | 2023 |
Prolongation of metallothionein induction combats Aß and α-synuclein toxicity in aged transgenic Caenorhabditis elegans.
Topics: Aging; alpha-Synuclein; Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modi | 2020 |